Shazia Usmani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shazia Usmani has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Shadma Wahab
Department of Pharmacognosy College of Pharmacy King Khalid University Abha Saudi Arabia
5 shared publications - Abdul Hafeez
Faculty of Pharmacy, Integral University, Lucknow, 226026, India
3 shared publications - Farogh Ahsan
Department of Pharmacy, Integral University, Lucknow, India
3 shared publications - Irfan Ahmad
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia
3 shared publications - Priyanka Bajpai
Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, Uttar Pradesh, India
3 shared publications Shabana Khatoon
Department of Pharmacy Herbal Bioactive Research Laboratory Integral University Dasauli Kursi Road Lucknow Uttar Pradesh INDIA
3 shared publications
Latest Publications
- 28 September 2026
- Published by Springer Nature in Clinical & Translational Metabolism
- Vol. 24  (1) , 21
Osteoprotective Effects of Sesamol and Glyburide in an Ovariectomized Rat Model of Postmenopausal Osteoporosis
- 28 September 2026
- Published by Springer Nature in Clinical & Translational Metabolism
- Vol. 24  (1) , 21
Osteoprotective Effects of Sesamol and Glyburide in an Ovariectomized Rat Model of Postmenopausal Osteoporosis
- 29 September 2025
- Published by Manuscript Technomedia LLP in Pharmacognosy Research
- Vol. 17  (4) , 1328-1334
Flavonoid Rich Fraction of Methanol Extract of Capparis decidua Attenuates MDA-MB-231 Breast Cancer Cells
Background: The research investigated the mechanism behind the antiproliferative activity of Capparis decidua (Family: Capparaceae). Despite being tested for other cell lines, its mechanism of action is still not well established. Objectives: To evaluate the anticancer potential of the ethylacetate fraction of methanolic extract of C. decidua and explore the mechanism involved to validate its role in adjuvant therapy. Materials and Methods: This research, evaluated the ethylacetate fraction, through MTT, the cell viability assay. Reactive oxygen species, also known as ROS, generation was used to gauge the extent of oxidative stress in the cytosol. DAPI staining and mitochondrial membrane potential was also performed. Results: The methanolic extract and its ethylacetate fraction induced considerable ROS generation intracellularly, which might be ascribed to the several flavonoids as ascertained by total flavonoid content findings. Apoptosis mediated cell death was observed against MDA-MB231. The methanolic extract as well as the fraction exhibited cytotoxicity for both cell lines based on the dosage. It was discerned that ROS levels amplified, along with depletion of the mitochondrial membrane potential, led to consequent apoptosis of cancer cells. This study is the first report of its kind, that ethylacetate fraction induces breast cancer cell death via apoptosis vis a vis depletion in mitochondrial potential. Conclusion: We conclude better anticancer potential in ethylacetate fraction of methanolic extract, which may prove to be a cost-effective alternative for adjuvant therapy against breast cancer.
- 29 September 2025
- Published by Manuscript Technomedia LLP in Pharmacognosy Research
- Vol. 17  (4) , 1328-1334
Flavonoid Rich Fraction of Methanol Extract of Capparis decidua Attenuates MDA-MB-231 Breast Cancer Cells
Background: The research investigated the mechanism behind the antiproliferative activity of Capparis decidua (Family: Capparaceae). Despite being tested for other cell lines, its mechanism of action is still not well established. Objectives: To evaluate the anticancer potential of the ethylacetate fraction of methanolic extract of C. decidua and explore the mechanism involved to validate its role in adjuvant therapy. Materials and Methods: This research, evaluated the ethylacetate fraction, through MTT, the cell viability assay. Reactive oxygen species, also known as ROS, generation was used to gauge the extent of oxidative stress in the cytosol. DAPI staining and mitochondrial membrane potential was also performed. Results: The methanolic extract and its ethylacetate fraction induced considerable ROS generation intracellularly, which might be ascribed to the several flavonoids as ascertained by total flavonoid content findings. Apoptosis mediated cell death was observed against MDA-MB231. The methanolic extract as well as the fraction exhibited cytotoxicity for both cell lines based on the dosage. It was discerned that ROS levels amplified, along with depletion of the mitochondrial membrane potential, led to consequent apoptosis of cancer cells. This study is the first report of its kind, that ethylacetate fraction induces breast cancer cell death via apoptosis vis a vis depletion in mitochondrial potential. Conclusion: We conclude better anticancer potential in ethylacetate fraction of methanolic extract, which may prove to be a cost-effective alternative for adjuvant therapy against breast cancer.
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 21  (3) , 287-296
An Insight into Herbal Interventions for Breast Cancer: A Comprehensive Review
New therapies for life-threatening ailments like breast carcinoma are urgently required to relieve the ever-increasing burden of the mortality associated with it. The very specific feature associated with life-giving natural products is their lesser toxicity concerning existing strategies viz chemotherapy or adjuvant modalities. In our review, we have tried to compile the existing data on exploring herbal extracts and bio-actives through various in vitro and in vivo techniques. An attempt has been made to accumulate data for a scrupulous literature review retrieved via pertinent keywords in authentic records. Web of Science, Scopus, and Science Direct. The major keywords included herbal extract, in vitro, anticancer, and metastasis. A comprehensive exploration unveiled an imperative role against malignancies of various tissues, but we focussed on breast cancer cell lines. Still, extensive reports on herbal alternatives and their bio-active mechanism are highly implicated in tapping their potential as standardized regimens. Scientific evidence, correlations, and proper safety data may substantiate interventions in cancer therapy.
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 21  (3) , 287-296
An Insight into Herbal Interventions for Breast Cancer: A Comprehensive Review
New therapies for life-threatening ailments like breast carcinoma are urgently required to relieve the ever-increasing burden of the mortality associated with it. The very specific feature associated with life-giving natural products is their lesser toxicity concerning existing strategies viz chemotherapy or adjuvant modalities. In our review, we have tried to compile the existing data on exploring herbal extracts and bio-actives through various in vitro and in vivo techniques. An attempt has been made to accumulate data for a scrupulous literature review retrieved via pertinent keywords in authentic records. Web of Science, Scopus, and Science Direct. The major keywords included herbal extract, in vitro, anticancer, and metastasis. A comprehensive exploration unveiled an imperative role against malignancies of various tissues, but we focussed on breast cancer cell lines. Still, extensive reports on herbal alternatives and their bio-active mechanism are highly implicated in tapping their potential as standardized regimens. Scientific evidence, correlations, and proper safety data may substantiate interventions in cancer therapy.
- 20 June 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 184, 362-375
Identification of rosmarinic acid as a potent inhibitor of integrin-linked kinase (ILK) with anticancer activity in breast cancer cells
- 20 June 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 184, 362-375
Identification of rosmarinic acid as a potent inhibitor of integrin-linked kinase (ILK) with anticancer activity in breast cancer cells
- Open Access
- 6 June 2025
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 41  (3) , 1053-1066
Development and Validation of a Novel and Robust RP-HPLC Method for the Simultaneous Estimation of Metformin and Sesamol, and its Application in an In-house Developed Nanoliposomal Formulation
This study introduces a unique High-Performance Liquid Chromatography (HPLC) method for quantifying Metformin and Sesamol simultaneously in pharmaceuticals. The technique uses a reverse-phase C18 column with acetonitrile and water in a gradient pattern with UV detection. The method demonstrated good linearity for Metformin and Sesamol at concentrations ranging from 20-1.25 μg/ml, with coefficients of correlation (r²) of 0.9947 and 0.9908, respectively. The method demonstrated excellent repeatability, with precision measured as RSD below 2% for intra-day and inter-day measurements. The method's accuracy was proven through recovery tests. The Metformin's LOD and LOQ reported as 0.89 μg/mL & 2.71 μg/ml, and Sesamol's as 1.27 μg/ml & 3.86 μg/ml, respectively. The approach also demonstrated resilience to minor fluctuations in method parameters, making it suitable for regular analysis. This validated HPLC technique was successfully used for the simultaneous measurement of Metformin and Sesamol in a nanoliposomal formulation, providing a reliable tool for quality control.
- 6 June 2025
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 41  (3) , 1053-1066
Open AccessDevelopment and Validation of a Novel and Robust RP-HPLC Method for the Simultaneous Estimation of Metformin and Sesamol, and its Application in an In-house Developed Nanoliposomal Formulation
This study introduces a unique High-Performance Liquid Chromatography (HPLC) method for quantifying Metformin and Sesamol simultaneously in pharmaceuticals. The technique uses a reverse-phase C18 column with acetonitrile and water in a gradient pattern with UV detection. The method demonstrated good linearity for Metformin and Sesamol at concentrations ranging from 20-1.25 μg/ml, with coefficients of correlation (r²) of 0.9947 and 0.9908, respectively. The method demonstrated excellent repeatability, with precision measured as RSD below 2% for intra-day and inter-day measurements. The method's accuracy was proven through recovery tests. The Metformin's LOD and LOQ reported as 0.89 μg/mL & 2.71 μg/ml, and Sesamol's as 1.27 μg/ml & 3.86 μg/ml, respectively. The approach also demonstrated resilience to minor fluctuations in method parameters, making it suitable for regular analysis. This validated HPLC technique was successfully used for the simultaneous measurement of Metformin and Sesamol in a nanoliposomal formulation, providing a reliable tool for quality control.
- 24 June 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13  (2) , e10545
An update on natural bioactive components of traditional preparations for the treatment of nephrolithiasis; a review
Nephrolithiasis is a condition characterized by the formation of crystal concretions within the kidneys or urinary tract. This urological disorder is on the rise globally, affecting both male and female populations. Unfortunately, conventional medicines used in the treatment of nephrolithiasis often lead to certain complications, eventually resulting in end-stage renal disease. As a result, there has been a growing interest in seeking risk-free therapies from nature to address this issue caused by the undesired effects of synthetic drugs. Evidence-based traditional medicine has emerged as a significant approach to treating nephrolithiasis, gaining recognition within the scientific community. In this review, we summarize recent scientific reports on various herbal drugs with clinical relevance in the treatment of nephrolithiasis, utilizing them as part of traditional medicine practices in the Asian continent. Additionally, several traditional medicine formulations from Ayurveda, Unani, and homeopathic systems, known for their potential lithotriptic effects and clinical applications, are highlighted. The primary focus of this review is to explore the mechanisms involved in the formation of kidney stones and provide a concise compilation of therapeutically effective herbs used in nephrolithiasis treatment.
- 24 June 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13  (2) , e10545
An update on natural bioactive components of traditional preparations for the treatment of nephrolithiasis; a review
Nephrolithiasis is a condition characterized by the formation of crystal concretions within the kidneys or urinary tract. This urological disorder is on the rise globally, affecting both male and female populations. Unfortunately, conventional medicines used in the treatment of nephrolithiasis often lead to certain complications, eventually resulting in end-stage renal disease. As a result, there has been a growing interest in seeking risk-free therapies from nature to address this issue caused by the undesired effects of synthetic drugs. Evidence-based traditional medicine has emerged as a significant approach to treating nephrolithiasis, gaining recognition within the scientific community. In this review, we summarize recent scientific reports on various herbal drugs with clinical relevance in the treatment of nephrolithiasis, utilizing them as part of traditional medicine practices in the Asian continent. Additionally, several traditional medicine formulations from Ayurveda, Unani, and homeopathic systems, known for their potential lithotriptic effects and clinical applications, are highlighted. The primary focus of this review is to explore the mechanisms involved in the formation of kidney stones and provide a concise compilation of therapeutically effective herbs used in nephrolithiasis treatment.
- Open Access
- 1 June 2024
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 2  (3) , 291-304
Recent advances in anticancer approach of traditional medicinal plants: A novel strategy for cancer chemotherapy
- 1 June 2024
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 2  (3) , 291-304
Open AccessRecent advances in anticancer approach of traditional medicinal plants: A novel strategy for cancer chemotherapy
- 10 October 2023
- Published by Bentham Science Publishers Ltd.
- p. 137-168
Treatment of Scabies with Herbal Medicines
Scabies is a chronic and serious community disorder caused by a parasite commonly known as a mite (Sarcoptes scabiei var hominis). The long-term infection may lead to chronic complications such as septicemia, acute post-streptococcal glomerulonephritis, heart disease, and secondary infections. The majority of novel medicinal agents from various plant sources are responsible for the management and treatment of several types of chronic disorders. The safe and cost-effective alternative treatment strategy is the use of medicinal plants that plays a potential role against a variety of diseases due to the presence of numerous types of active phytochemicals with no or negligible adverse effect. This study gives a unique summary, including a correlation between traditional medicinal plants and their derived active phytochemicals for the significant treatment of scabies. The literature search was carried out via search engines through different databases, including Google Scholar, PubMed, Medline, ScienceDirect, etc. A large number of medicinal plants and their active medicinal agents have been reviewed with remarkable therapeutic effects against scabies. There are some limitations due to insufficient data related to limited pre-clinical and clinical trials in this particular area. This review provides a baseline to explore the therapeutic potential of these medicinal plants against skin diseases, especially scabies. However, extensive studies are required to identify, authenticate, and characterize the bioactive compounds present in these plants, which may lead to value addition in pharmaceutical industries by providing a cost-effective way of treatment with minimal side effects.
- 10 October 2023
- Published by Bentham Science Publishers Ltd.
- p. 137-168
Treatment of Scabies with Herbal Medicines
Scabies is a chronic and serious community disorder caused by a parasite commonly known as a mite (Sarcoptes scabiei var hominis). The long-term infection may lead to chronic complications such as septicemia, acute post-streptococcal glomerulonephritis, heart disease, and secondary infections. The majority of novel medicinal agents from various plant sources are responsible for the management and treatment of several types of chronic disorders. The safe and cost-effective alternative treatment strategy is the use of medicinal plants that plays a potential role against a variety of diseases due to the presence of numerous types of active phytochemicals with no or negligible adverse effect. This study gives a unique summary, including a correlation between traditional medicinal plants and their derived active phytochemicals for the significant treatment of scabies. The literature search was carried out via search engines through different databases, including Google Scholar, PubMed, Medline, ScienceDirect, etc. A large number of medicinal plants and their active medicinal agents have been reviewed with remarkable therapeutic effects against scabies. There are some limitations due to insufficient data related to limited pre-clinical and clinical trials in this particular area. This review provides a baseline to explore the therapeutic potential of these medicinal plants against skin diseases, especially scabies. However, extensive studies are required to identify, authenticate, and characterize the bioactive compounds present in these plants, which may lead to value addition in pharmaceutical industries by providing a cost-effective way of treatment with minimal side effects.